From: Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19
Cause | Disease type |
---|---|
Factors that increase the risk of bleeding | Hereditary coagulation factor deficiency (such as hemophilia), fibrinogen reduction, platelet deficiency, etc. |
Acquired clotting factor reduction, hyperfibrinolysis, thrombocytopenia, etc. | |
History of taking anticoagulant or antiplatelet drugs | |
Diseases such as bronchiectasis, peptic ulcer, liver cirrhosis and hemorrhoids | |
24 h after severe trauma or surgery | |
Factors that cause thromboembolism | Congenital deficiency of anticoagulants (eg, antithrombin (AT) deficiency, protein C/S deficiency) |
Diabetes, systemic lupus erythematosus, antiphospholipid syndrome, systemic vasculitis and other underlying diseases which have vascular endothelial cells damage | |
History of thrombotic diseases such as venous thrombosis, cerebral thrombosis, arterial embolism, myocardial infarction | |
A state of shock | |
Bed-ridden | |
Surgery | |
Complications with acute infections |